메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background: Asthma is a disease characterized by chronic airway inflammation and airway hyperresponsiveness. Immunoglobulin E (IgE) plays a key role in the pathogenesis of allergic diseases and asthma. Recently, nonanaphylactogenic antihuman IgE antibody has been used as a therapeutic agent for asthma. Objective: The present study investigated the effect of anti-IgE antibody on the airway inflammation and hyperresponsiveness (AHR) in a mouse model of chronic asthma. Method: We developed a mouse model of chronic asthma for which ovalbumin (OVA)-sensitized female BALB/c- mice were repeatedly exposed to intranasal OVA administration twice a week for 3 months. Anti-IgE antibodies were intravenously administered starting on the 38th day, he next day after 3 challenges and there after once a month during the intranasal OVA challenge of 3 months. Result: Mice chronically exposed to OVA developed sustained eosinophilic airway inflammation and AHR to methacholine compared with control mice. Treatment with anti-IgE antibody inhibited the development of AHR and eosinophilic inflammation. Moreover, anti-IgE antibody treatment reduced the interleukin-5 and interleukin-13 in bronchoalveolar lavage fluid but did not show the change in interleukin-10 and transforming growth factor-β1 levels. Conclusion: These results suggest that anti-IgE treatment can modulate airway inflammation via regulation of Th2 cytokines.

목차

등록된 정보가 없습니다.

참고문헌 (25)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0